Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML

Key Points Expression of CALCRL is an independent prognostic factor and a potential therapeutic target in pediatric AML. CALCRL is linked with relapse risk in p ediatric AML, which supports its role as a master regulator of relapse-initiating drug-tolerant cells.

[1]  A. Stevens,et al.  Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy , 2021, Current Oncology Reports.

[2]  J. Tamburini,et al.  Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells , 2020, Nature Communications.

[3]  R. Schiff,et al.  The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells , 2019, Proceedings of the National Academy of Sciences.

[4]  W. Hiddemann,et al.  The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia , 2019, Leukemia.

[5]  B. Leber,et al.  Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence. , 2018, Cancer cell.

[6]  D. Reinhardt,et al.  Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 , 2018, Leukemia.

[7]  Hamid Bolouri,et al.  The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions , 2017, Nature Medicine.

[8]  D. Gerhard,et al.  MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Carroll,et al.  Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. , 2017, Cancer discovery.

[10]  Eva Steliarova-Foucher,et al.  International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.

[11]  D. Pollyea,et al.  Therapeutic targeting of acute myeloid leukemia stem cells. , 2017, Blood.

[12]  Claude Preudhomme,et al.  A 17-gene stemness score for rapid determination of risk in acute leukaemia , 2016, Nature.

[13]  Asim Khwaja,et al.  Acute myeloid leukaemia , 2016, Nature Reviews Disease Primers.

[14]  H. Glimm,et al.  Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia , 2015, Molecular carcinogenesis.

[15]  I. Larráyoz,et al.  Adrenomedullin and tumour microenvironment , 2014, Journal of Translational Medicine.

[16]  S. Brain,et al.  Calcitonin gene-related peptide: physiology and pathophysiology. , 2014, Physiological reviews.

[17]  S. Raimondi,et al.  Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Bertin,et al.  Adrenomedullin Blockade Suppresses Growth of Human Hormone–Independent Prostate Tumor Xenograft in Mice , 2013, Clinical Cancer Research.

[19]  S. Raimondi,et al.  AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia , 2012, Cancer.

[20]  Yongzhang Luo,et al.  Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner , 2011, Clinical Cancer Research.

[21]  Christophe Dussert,et al.  Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  H. Salih,et al.  Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans. , 2009, Cancer research.

[23]  Y. Kurihara,et al.  Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide , 2008, Proceedings of the National Academy of Sciences.

[24]  S. Feig,et al.  Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. , 2008, Blood.

[25]  L. Kanz,et al.  CDCP1 Is a Novel Marker for Hematopoietic Stem Cells , 2003, Annals of the New York Academy of Sciences.

[26]  Torsten Hothorn,et al.  On the Exact Distribution of Maximally Selected Rank Statistics , 2002, Comput. Stat. Data Anal..

[27]  N. Brünner,et al.  Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. , 2002, The American journal of pathology.